Bioqual PE Ratio 2010-2023 | BIOQ
Current and historical p/e ratio for Bioqual (BIOQ) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bioqual PE ratio as of May 03, 2024 is 67.76.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Bioqual PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 0.00 | nan | ||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.063B |
| BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.269B | 10.45 |
| Quest Diagnostics (DGX) | United States | $15.262B | 15.77 |
| DaVita (DVA) | United States | $11.791B | 14.65 |
| Chemed (CHE) | United States | $8.503B | 26.36 |
| Encompass Health (EHC) | United States | $8.333B | 21.45 |
| Elanco Animal Health (ELAN) | United States | $6.685B | 15.20 |
| Option Care Health (OPCH) | United States | $5.181B | 19.61 |
| RadNet (RDNT) | United States | $3.783B | 102.40 |
| Amedisys (AMED) | United States | $3.009B | 21.31 |
| LifeStance Health (LFST) | United States | $2.546B | 0.00 |
| Astrana Health (ASTH) | United States | $2.099B | 26.20 |
| Addus HomeCare (ADUS) | United States | $1.608B | 24.43 |
| U.S Physical Therapy (USPH) | United States | $1.585B | 41.09 |
| Pennant (PNTG) | United States | $0.642B | 37.54 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.448B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.343B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.026B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.019B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.011B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |